Results 1 to 10 of about 74,737 (254)
International Guillain-Barré Syndrome Outcome Study (IGOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome [PDF]
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatment of
Bateman, K. +49 more
core +39 more sources
A rare case of paraneoplastic Guillain-Barré syndrome in a patient with endometrial cancer
Introduction: Guillain-Barré syndrome is an acute, inflammatory polyradiculoneuropathy of autoimmune aetiology. It is a rare disease seen in 1 in 100,000 person-years.
Asif Mohamed Farook +3 more
doaj +1 more source
Acute onset of Guillain-Barré syndrome after multiple spine surgeries: A rare case report
Guillain-Barré syndrome is an autoimmune disorder presented by ascending paralysis and areflexia. The condition has been reported after many infections, but Guillain-Barré syndrome after spine surgery is rare. We, herein, present a case of Guillain-Barré
Khalil Komlakh +5 more
doaj +1 more source
Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic ...
Pieter A. Doorn +20 more
semanticscholar +1 more source
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications.
S. Waheed +4 more
semanticscholar +1 more source
Mounting evidence supports an association between Guillain−Barré syndrome spectrum (GBSs) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
L. Palaiodimou +13 more
semanticscholar +1 more source
Guillain–Barré Syndrome Associated with SARS-CoV-2
Guillain–Barre Syndrome with Covid-19 Five patients who had Guillain–Barre syndrome 5 to 10 days after the onset of Covid-19 are described.
G. Toscano +11 more
semanticscholar +1 more source
Guillain Barre syndrome associated with COVID-19 infection: A case report
Novel outbreak with coronavirus 2019 began since 31 December 2019. Coronaviruses can cause multiple systemic infections that respiratory complications are the most obvious symptoms. In this report, we describe the symptoms of Guillain Barre syndrome (GBS)
Z. Sedaghat, N. Karimi
semanticscholar +1 more source
Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination
Although SARS‐CoV‐2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthesias variant of Guillain–Barré syndrome (GBS) occurring within 3 weeks of vaccination with the Oxford–AstraZeneca SARS‐CoV‐2 vaccine.
C. Allen +6 more
semanticscholar +1 more source
Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several pieces of evidence suggested an association between the spectrum of Guillain–Barré syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Samir Abu-Rumeileh +4 more
semanticscholar +1 more source

